Ligand validation:6XL4

Q6K: ~{N}-[2-[2-(dimethylamino)ethyl-methyl-amino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]propanamide

Q6K is a Ligand Of Interest in 6XL4 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6XL4_Q6K_A_1301	62%	2%	0.143	0.935	5.26	2	24	12	1	0	100%	1
6XL4_Q6K_B_1202	37%	1%	0.187	0.883	5.25	2.18	24	13	2	0	100%	1
8GK5_Q6K_B_1101	55%	25%	0.146	0.915	1.32	1.72	5	12	0	0	100%	1
6Z4B_Q6K_A_1101	48%	13%	0.17	0.914	1.79	2.12	8	12	1	0	100%	1
7LGS_Q6K_C_1101	36%	28%	0.249	0.946	0.98	1.89	2	12	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.